News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,029 Results
Type
Article (44252)
Company Profile (314)
Press Release (700442)
Multimedia
Podcasts (101)
Webinars (22)
Section
Business (208613)
Career Advice (2109)
Deals (36023)
Drug Delivery (131)
Drug Development (82640)
Employer Resources (174)
FDA (16649)
Job Trends (15220)
News (352295)
Policy (33110)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2687)
Academic (1)
Accelerated approval (48)
Adcomms (27)
Allergies (173)
Alliances (51107)
ALS (214)
Alzheimer's disease (1822)
Antibody-drug conjugate (ADC) (453)
Approvals (17014)
Artificial intelligence (713)
Autoimmune disease (294)
Automation (57)
Bankruptcy (366)
Best Places to Work (11781)
BIOSECURE Act (21)
Biosimilars (221)
Biotechnology (210)
Bladder cancer (188)
Brain cancer (72)
Breast cancer (757)
Cancer (5867)
Cardiovascular disease (473)
Career advice (1794)
Career pathing (43)
CAR-T (333)
CDC (58)
Celiac Disease (3)
Cell therapy (905)
Cervical cancer (47)
Clinical research (71595)
Collaboration (2123)
Company closure (5)
Compensation (1399)
Complete response letters (81)
COVID-19 (2776)
CRISPR (111)
C-suite (1150)
Cystic fibrosis (154)
Data (7933)
Decentralized trials (3)
Denatured (33)
Depression (164)
Dermatology (87)
Diabetes (598)
Diagnostics (7027)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (346)
Drug pricing (206)
Drug shortages (31)
Duchenne muscular dystrophy (285)
Earnings (92961)
Editorial (68)
Employer branding (21)
Employer resources (153)
Events (122178)
Executive appointments (1106)
FDA (20382)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1758)
Gene editing (239)
Generative AI (60)
Gene therapy (729)
GLP-1 (1076)
Government (4805)
Grass and pollen (6)
Guidances (408)
Healthcare (19271)
HIV (80)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (294)
Immuno-oncology (93)
Indications (191)
Infectious disease (3117)
Inflammatory bowel disease (221)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (292)
Interviews (334)
IPO (16840)
IRA (51)
Job creations (3756)
Job search strategy (1490)
JPM (61)
Kidney cancer (19)
Labor market (100)
Layoffs (583)
Leadership (40)
Legal (8042)
Liver cancer (99)
Longevity (32)
Lung cancer (765)
Lymphoma (430)
Machine learning (64)
Management (60)
Manufacturing (1056)
MASH (187)
Medical device (14032)
Medtech (14156)
Mergers & acquisitions (20422)
Metabolic disorders (1519)
mRNA (210)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (423)
Neuropsychiatric disorders (106)
Neuroscience (3353)
Neurotech (1)
NextGen: Class of 2026 (6714)
Non-profit (4632)
Now hiring (78)
Obesity (708)
Opinion (299)
Ovarian cancer (221)
Pain (258)
Pancreatic cancer (301)
Parkinson's disease (371)
Partnered (34)
Patents (598)
Patient recruitment (680)
Peanut (62)
People (60699)
Pharmaceutical (63)
Pharmacy benefit managers (35)
Phase 1 (22430)
Phase 2 (31580)
Phase 3 (23371)
Pipeline (8771)
Policy (329)
Postmarket research (2577)
Preclinical (9648)
Press Release (69)
Prostate cancer (303)
Psychedelics (54)
Radiopharmaceuticals (327)
Rare diseases (1095)
Real estate (6104)
Recruiting (70)
Regulatory (25637)
Reports (56)
Research institute (2504)
Resumes & cover letters (359)
Rett syndrome (39)
RNA editing (23)
RSV (88)
Schizophrenia (178)
Series A (296)
Series B (218)
Service/supplier (12)
Sickle cell disease (113)
Special edition (27)
Spinal muscular atrophy (168)
Sponsored (50)
Startups (3767)
State (2)
Stomach cancer (18)
Supply chain (128)
Tariffs (89)
The Weekly (66)
Vaccines (1103)
Venture capital (109)
Weight loss (457)
Women's health (125)
Worklife (21)
Date
Today (3)
Last 7 days (863)
Last 30 days (3487)
Last 365 days (30647)
2026 (12654)
2025 (30807)
2024 (35876)
2023 (40672)
2022 (51799)
2021 (56344)
2020 (54744)
2019 (47334)
2018 (35589)
2017 (32951)
2016 (32281)
2015 (38223)
2014 (31983)
2013 (27100)
2012 (29255)
2011 (29939)
2010 (27956)
Location
Africa (780)
Alabama (95)
Alaska (7)
Arizona (351)
Arkansas (15)
Asia (41045)
Australia (6736)
California (13421)
Canada (3787)
China (1372)
Colorado (576)
Connecticut (597)
Delaware (405)
Europe (89392)
Florida (1994)
Georgia (430)
Hawaii (3)
Idaho (63)
Illinois (1076)
India (91)
Indiana (606)
Iowa (24)
Japan (539)
Kansas (134)
Kentucky (52)
Louisiana (41)
Maine (76)
Maryland (1624)
Massachusetts (9667)
Michigan (363)
Minnesota (733)
Mississippi (6)
Missouri (156)
Montana (36)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3574)
New Mexico (31)
New York (3503)
North Carolina (1727)
North Dakota (10)
Northern California (6710)
Ohio (397)
Oklahoma (23)
Oregon (42)
Pennsylvania (2688)
Puerto Rico (29)
Rhode Island (50)
South America (1159)
South Carolina (85)
South Dakota (2)
Southern California (5299)
Tennessee (212)
Texas (2124)
United States (47516)
Utah (399)
Vermont (1)
Virginia (331)
Washington D.C. (82)
Washington State (1073)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
745,029 Results for "x rx discovery inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Claritas Rx Chief Technology Officer Bhupesh Bajaj Named to PM360 ELITE 100 List
May 14, 2026
·
1 min read
Press Releases
Neurolief to Showcase Proliv®Rx at APA 2026, Highlighting FDA-Approved, Physician-Directed At-Home Brain Stimulation for Major Depressive Disorder
May 12, 2026
·
5 min read
Press Releases
MedImpact Completes Acquisition of Sav-Rx
February 3, 2026
·
2 min read
Press Releases
Longitude Rx Appoints Stacy Walton as Inaugural Chief Commercial Officer to Accelerate Growth and Market Expansion
April 1, 2026
·
2 min read
Job Trends
Innovation Pressure Cooker: Tackling Drug Discovery’s Biggest Challenges
Drug discovery can be an uphill battle, especially lately given recent upheaval at the FDA and muted investment activity.
BioSpace
spoke to four industry executives about key issues facing those working in this space, starting with planning around uncertainty.
April 2, 2026
·
5 min read
·
Angela Gabriel
Press Releases
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
March 26, 2026
·
6 min read
Press Releases
Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants
March 30, 2026
·
3 min read
Press Releases
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
May 7, 2026
·
10 min read
Press Releases
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
April 23, 2026
·
1 min read
Press Releases
Claritas Rx Unveils Integrated Data and Consent Solution That Drives Higher First Fill Rates and Long-Term Persistence Across Specialty and Rare Brands
February 26, 2026
·
3 min read
1 of 74,503
Next
